These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 22522778

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Raval AD, Hunter T, Stuckey B, Hart RJ.
    Cochrane Database Syst Rev; 2011 Oct 05; (10):CD008565. PubMed ID: 21975784
    [Abstract] [Full Text] [Related]

  • 26. The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome - a preliminary study.
    Dravecká I, Figurová J, Javorský M, Petríková J, Vaľková M, Lazúrová I.
    Physiol Res; 2016 Nov 23; 65(5):815-822. PubMed ID: 27429113
    [Abstract] [Full Text] [Related]

  • 27. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA, Shin SY, Yoon BK, Choi D.
    Gynecol Endocrinol; 2007 Nov 23; 23(8):461-7. PubMed ID: 17852414
    [Abstract] [Full Text] [Related]

  • 28. Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients.
    Garzia E, Galiano V, Marfia G, Navone S, Grossi E, Marconi AM.
    Reprod Biol Endocrinol; 2022 Jan 04; 20(1):6. PubMed ID: 34983571
    [Abstract] [Full Text] [Related]

  • 29. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 04; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 30. A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.
    Sathyapalan T, Cho LW, Kilpatrick ES, Coady AM, Atkin SL.
    Clin Endocrinol (Oxf); 2008 Dec 04; 69(6):931-5. PubMed ID: 18410553
    [Abstract] [Full Text] [Related]

  • 31. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.
    Gynecol Endocrinol; 2002 Jun 04; 16(3):217-24. PubMed ID: 12192894
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    Diamanti-Kandarakis E, Kouli C, Tsianateli T, Bergiele A.
    Eur J Endocrinol; 1998 Mar 04; 138(3):269-74. PubMed ID: 9539300
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
    Abdel-Maboud M, Menshawy A, Hasabo EA, Abdelraoof MI, Alshandidy M, Eid M, Menshawy E, Outani O, Menshawy A.
    PLoS One; 2021 Mar 04; 16(7):e0254412. PubMed ID: 34280195
    [Abstract] [Full Text] [Related]

  • 35. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
    Ibáñez L, Valls C, Potau N, Marcos MV, de Zegher F.
    J Clin Endocrinol Metab; 2000 Oct 04; 85(10):3526-30. PubMed ID: 11061495
    [Abstract] [Full Text] [Related]

  • 36. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S, Akhtar N, Ahmad J.
    Diabetes Metab Syndr; 2012 Oct 04; 6(4):207-11. PubMed ID: 23199540
    [Abstract] [Full Text] [Related]

  • 37. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov 04; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 38. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M.
    J Endocrinol Invest; 2005 Dec 04; 28(11):1003-8. PubMed ID: 16483179
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.